Predicted to enable molecular adaptor activity. Involved in asymmetric cell division; polarity specification of anterior/posterior axis; and positive regulation of metaphase/anaphase transition of meiosis I. Predicted to be part of anaphase-promoting complex. Is an ortholog of human CDC23 (cell division cycle 23).
Predicted to enable ubiquitin protein ligase binding activity. Predicted to be involved in metaphase/anaphase transition of mitotic cell cycle and protein K11-linked ubiquitination. Predicted to be part of anaphase-promoting complex. Human ortholog(s) of this gene implicated in several diseases, including acute myeloid leukemia; lung disease (multiple); and primary angle-closure glaucoma. Is an ortholog of human ANAPC2 (anaphase promoting complex subunit 2).
Enables ubiquitin-protein transferase activity. Involved in anaphase-promoting complex-dependent catabolic process; embryo development; and meiotic chromosome segregation. Predicted to be located in nucleus. Predicted to be part of anaphase-promoting complex. Expressed in germ line. Is an ortholog of human ANAPC11 (anaphase promoting complex subunit 11).
Predicted to be involved in protein K11-linked ubiquitination. Predicted to be part of anaphase-promoting complex. Is an ortholog of human ANAPC10 (anaphase promoting complex subunit 10).
Predicted to be involved in protein K11-linked ubiquitination. Predicted to be part of anaphase-promoting complex. Is an ortholog of human ANAPC10 (anaphase promoting complex subunit 10).
Expressed in body wall musculature; germ line; hypodermis; intestine; and pharynx. Is predicted to encode a protein with the following domains: Phosducin, N-terminal domain superfamily; Phosducin; Thioredoxin-like superfamily; and Phosducin, thioredoxin-like domain. Is an ortholog of human PDC (phosducin) and PDCL (phosducin like).